annual operating profit:
-$153.46M-$124.73M(-434.17%)Summary
- As of today (June 17, 2025), IMNM annual operating income is -$153.46 million, with the most recent change of -$124.73 million (-434.17%) on December 31, 2024.
- During the last 3 years, IMNM annual operating profit has fallen by -$128.25 million (-508.86%).
- IMNM annual operating profit is now -1881.87% below its all-time high of -$7.74 million, reached on December 31, 2018.
Performance
IMNM Operating profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating profit:
-$44.64M+$10.96M(+19.72%)Summary
- As of today (June 17, 2025), IMNM quarterly operating income is -$44.64 million, with the most recent change of +$10.96 million (+19.72%) on March 31, 2025.
- Over the past year, IMNM quarterly operating profit has dropped by -$24.29 million (-119.40%).
- IMNM quarterly operating profit is now -1581.21% below its all-time high of -$2.65 million, reached on March 31, 2020.
Performance
IMNM quarterly operating profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM operating profit:
-$177.75M-$24.29M(-15.83%)Summary
- As of today (June 17, 2025), IMNM TTM operating income is -$177.75 million, with the most recent change of -$24.29 million (-15.83%) on March 31, 2025.
- Over the past year, IMNM TTM operating profit has dropped by -$133.15 million (-298.52%).
- IMNM TTM operating profit is now -6434.82% below its all-time high of -$2.72 million, reached on September 30, 2019.
Performance
IMNM TTM operating profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating profit Formula
Operating Profit = Gross Profit − Operating Expenses
IMNM Operating profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -434.2% | -119.4% | -298.5% |
| 3 y3 years | -508.9% | -283.0% | -439.3% |
| 5 y5 years | -1383.0% | -1581.2% | -2051.1% |
IMNM Operating profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -508.9% | at low | -898.3% | +19.7% | -684.3% | at low |
| 5 y | 5-year | -1383.0% | at low | -1581.2% | +19.7% | -2051.1% | at low |
| alltime | all time | -1881.9% | at low | -1581.2% | +19.7% | -6434.8% | at low |
IMNM Operating profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$44.64M(-19.7%) | -$177.75M(+15.8%) |
| Dec 2024 | -$153.46M(+434.2%) | -$55.60M(+26.9%) | -$153.46M(+37.4%) |
| Sep 2024 | - | -$43.82M(+30.0%) | -$111.71M(+54.0%) |
| Jun 2024 | - | -$33.70M(+65.6%) | -$72.53M(+62.6%) |
| Mar 2024 | - | -$20.34M(+46.9%) | -$44.60M(+55.3%) |
| Dec 2023 | -$28.73M(-22.1%) | -$13.85M(+199.0%) | -$28.73M(+26.8%) |
| Sep 2023 | - | -$4.63M(-19.7%) | -$22.66M(-14.7%) |
| Jun 2023 | - | -$5.77M(+29.1%) | -$26.57M(-10.6%) |
| Mar 2023 | - | -$4.47M(-42.6%) | -$29.72M(-19.5%) |
| Dec 2022 | -$36.90M | -$7.79M(-8.8%) | -$36.90M(-0.2%) |
| Sep 2022 | - | -$8.53M(-4.4%) | -$36.96M(+2.2%) |
| Jun 2022 | - | -$8.93M(-23.4%) | -$36.15M(+9.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$11.65M(+48.6%) | -$32.96M(+30.8%) |
| Dec 2021 | -$25.20M(+105.6%) | -$7.84M(+1.6%) | -$25.20M(+17.6%) |
| Sep 2021 | - | -$7.72M(+34.5%) | -$21.43M(+29.7%) |
| Jun 2021 | - | -$5.74M(+47.3%) | -$16.53M(+22.4%) |
| Mar 2021 | - | -$3.90M(-4.3%) | -$13.50M(+10.1%) |
| Dec 2020 | -$12.26M(+18.5%) | -$4.07M(+44.5%) | -$12.26M(+10.7%) |
| Sep 2020 | - | -$2.82M(+3.8%) | -$11.08M(+0.9%) |
| Jun 2020 | - | -$2.71M(+2.3%) | -$10.98M(+32.9%) |
| Mar 2020 | - | -$2.65M(-8.1%) | -$8.26M(+47.3%) |
| Dec 2019 | -$10.35M(+33.6%) | -$2.89M(+6.2%) | -$5.61M(+106.2%) |
| Sep 2019 | - | -$2.72M | -$2.72M |
| Dec 2018 | -$7.74M | - | - |
FAQ
- What is Immunome annual operating income?
- What is the all time high annual operating profit for Immunome?
- What is Immunome annual operating profit year-on-year change?
- What is Immunome quarterly operating income?
- What is the all time high quarterly operating profit for Immunome?
- What is Immunome quarterly operating profit year-on-year change?
- What is Immunome TTM operating income?
- What is the all time high TTM operating profit for Immunome?
- What is Immunome TTM operating profit year-on-year change?
What is Immunome annual operating income?
The current annual operating profit of IMNM is -$153.46M
What is the all time high annual operating profit for Immunome?
Immunome all-time high annual operating income is -$7.74M
What is Immunome annual operating profit year-on-year change?
Over the past year, IMNM annual operating income has changed by -$124.73M (-434.17%)
What is Immunome quarterly operating income?
The current quarterly operating profit of IMNM is -$44.64M
What is the all time high quarterly operating profit for Immunome?
Immunome all-time high quarterly operating income is -$2.65M
What is Immunome quarterly operating profit year-on-year change?
Over the past year, IMNM quarterly operating income has changed by -$24.29M (-119.40%)
What is Immunome TTM operating income?
The current TTM operating profit of IMNM is -$177.75M
What is the all time high TTM operating profit for Immunome?
Immunome all-time high TTM operating income is -$2.72M
What is Immunome TTM operating profit year-on-year change?
Over the past year, IMNM TTM operating income has changed by -$133.15M (-298.52%)